Role of B Cells in Breaking and Maintaining Tolerance to Clotting Factor VIII in Congenital and Acquired Hemophilia A
Immune responses directed against clotting factor FVIII (FVIII) seriously complicate treatments for patients with hemophilia A. This response can manifest in congenital hemophilia A patients who generate inhibitor antibodies that bind and inactivate “transplanted” replacement FVIII, as well as in ac...
Autores principales: | , , |
---|---|
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
MDPI AG
2014-04-01
|
Colección: | Antibodies |
Materias: | |
Acceso en línea: | http://www.mdpi.com/2073-4468/3/2/192 |